Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemopatch Performance Evaluation: A Prospective Observational Registry

NCT03392662 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

NCT NCT03392662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03392662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemopatch Performance Evaluation: A Prospective Observational Registry
Lead sponsor
Baxter Healthcare Corporation
Phase
Observational
Overall status
Completed
Start date
November 29, 2017
Completion date
January 28, 2019
Enrollment
621 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

air leakage, body fluid leakage, dura mater nick cut or tear, hemostatis